250 related articles for article (PubMed ID: 27417251)
1. Treatment of advanced group 2 PH.
Barnett CF; De Marco T
Prog Cardiovasc Dis; 2016; 59(1):78-86. PubMed ID: 27417251
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension due to left heart diseases.
Vachiéry JL; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs JS; Martinez F; Semigran M; Simonneau G; Wells A; Seeger W
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D100-8. PubMed ID: 24355634
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LV.
Rao SD; Menachem JN; Birati EY; Mazurek JA
Curr Heart Fail Rep; 2019 Oct; 16(5):119-129. PubMed ID: 31292856
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.
Haddad F; Kudelko K; Mercier O; Vrtovec B; Zamanian RT; de Jesus Perez V
Prog Cardiovasc Dis; 2011; 54(2):154-67. PubMed ID: 21875514
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular heart failure and pulmonary hypertension.
Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL
Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169
[TBL] [Abstract][Full Text] [Related]
6. Management of combined pre- and post-capillary pulmonary hypertension in advanced heart failure with reduced ejection fraction.
Sahay S; Khirfan G; Tonelli AR
Respir Med; 2017 Oct; 131():94-100. PubMed ID: 28947049
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.
Al-Omary MS; Sugito S; Boyle AJ; Sverdlov AL; Collins NJ
Hypertension; 2020 Jun; 75(6):1397-1408. PubMed ID: 32336230
[TBL] [Abstract][Full Text] [Related]
8. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications.
Guazzi M; Labate V
Curr Heart Fail Rep; 2016 Dec; 13(6):281-294. PubMed ID: 27858232
[TBL] [Abstract][Full Text] [Related]
10. Left Heart Disease and Pulmonary Hypertension: Are We Seeing the Full Picture?
Chung K; Strange G; Codde J; Celermajer D; Scalia GM; Playford D
Heart Lung Circ; 2018 Mar; 27(3):301-309. PubMed ID: 29102471
[TBL] [Abstract][Full Text] [Related]
11. Significance of Pulmonary Vascular Resistance and Diastolic Pressure Gradient on the New Definition of Combined Post-Capillary Pulmonary Hypertension.
Sugimoto K; Yoshihisa A; Nakazato K; Yokokawa T; Misaka T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Ishida T; Takeishi Y
Int Heart J; 2020; 61(2):301-307. PubMed ID: 32224602
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Hypertension secondary to Left Heart Disease.
Kabbach G; Mukherjee D
Curr Vasc Pharmacol; 2018; 16(6):555-560. PubMed ID: 28901848
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary hypertension – a common condition in left heart disease].
Lundgren J; Rådegran G
Lakartidningen; 2017 Dec; 114():. PubMed ID: 29292958
[TBL] [Abstract][Full Text] [Related]
14. When Pulmonary Hypertension Complicates Heart Failure.
Marra AM; Benjamin N; Cittadini A; Bossone E; Grünig E
Heart Fail Clin; 2020 Jan; 16(1):53-60. PubMed ID: 31735315
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension associated with left heart disease.
Adir Y; Amir O
Semin Respir Crit Care Med; 2013 Oct; 34(5):665-80. PubMed ID: 24037633
[TBL] [Abstract][Full Text] [Related]
16. Determinants and prognostic implications of the negative diastolic pulmonary pressure gradient in patients with pulmonary hypertension due to left heart disease.
Nagy AI; Venkateshvaran A; Merkely B; Lund LH; Manouras A
Eur J Heart Fail; 2017 Jan; 19(1):88-97. PubMed ID: 27748008
[TBL] [Abstract][Full Text] [Related]
17. Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation.
Al-Kindi SG; Farhoud M; Zacharias M; Ginwalla MB; ElAmm CA; Benatti RD; Oliveira GH
J Card Fail; 2017 Mar; 23(3):209-215. PubMed ID: 27374840
[TBL] [Abstract][Full Text] [Related]
18. Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure.
Kumarasinghe G; Jain P; Jabbour A; Lai J; Keogh AM; Kotlyar E; Jansz P; Macdonald PS; Hayward CS
ESC Heart Fail; 2018 Aug; 5(4):695-702. PubMed ID: 29573567
[TBL] [Abstract][Full Text] [Related]
19. [Pulmonary hypertension associated with left heart disease (group 2)].
Schmidt KH; Bikou O; Blindt R; Bruch L; Felgendreher R; Hohenforst-Schmidt W; Holt S; Ladage D; Pfeuffer-Jovic E; Rieth A; Schmeisser A; Schnitzler K; Stadler S; Steringer-Mascherbauer R; Yogeswaran A; Kuebler WM
Pneumologie; 2023 Nov; 77(11):926-936. PubMed ID: 37963482
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient.
Ibe T; Wada H; Sakakura K; Ikeda N; Yamada Y; Sugawara Y; Mitsuhashi T; Ako J; Fujita H; Momomura S
J Cardiol; 2016 Jun; 67(6):555-9. PubMed ID: 26299611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
